What's Happening?
European insurance regulators are increasing their scrutiny of how insurers value their investments in private credit. Authorities in France and Germany are among those stepping up their examination of the methods and data used by insurers to value these
assets. This move comes amid growing concerns about the private credit asset class, which has been affected by issues such as overspending on artificial intelligence and broader lending standards. The German watchdog BaFin is focusing on investment risk management and adherence to prudence standards, while France's ACPR has not commented. The scrutiny involves both direct lending to businesses and indirect investments via funds. The European Insurance and Occupational Pensions Authority (EIOPA) is also addressing risks from rising private equity ownership of insurers, highlighting issues like misaligned investment horizons and complex ownership structures.
Why It's Important?
The intensified scrutiny by European regulators on insurers' valuation of private credit is significant due to the potential impact on the financial stability of the insurance sector. Private credit, a $1.8 trillion industry, is challenging to value as it is not typically traded, leading to concerns about transparency and risk management. Insurers in the U.S. and Europe allocate a substantial portion of their assets to private credit, making the valuation methods critical for financial health. The increased regulatory focus aims to ensure that insurers have robust risk management practices and understand their investments thoroughly. This could lead to more stringent regulatory requirements and potentially affect the availability and cost of private credit, impacting businesses that rely on this form of financing.
What's Next?
As European regulators continue their scrutiny, insurers may need to enhance their risk management practices and valuation methods for private credit. The feedback process initiated by EIOPA on draft standards for acquiring insurers or substantial stakes in them will conclude by the end of April, potentially leading to new regulatory guidelines. Insurers might face increased pressure to provide more frequent and transparent valuations of their private credit exposures. This could result in changes to their investment strategies and a reevaluation of their asset allocations. The outcome of this regulatory scrutiny could also influence global insurance markets, as U.S. insurers are similarly invested in private credit.
